Alopecia

Cryotherapy may lower disease relapse in patients with alopecia areata compared with intralesional corticosteroid injections or topical steroids, according to a study.

Efficacy and safety outcomes in adolescents treated with ritlecitinib for severe alopecia areata were consistent with adults in the same indication, according to a subgroup analysis of a phase 2b/3 trial.

In this Healio video exclusive, George Martin, MD, discusses highlights from Maui Derm NP+PA, including recent approvals and new treatments for alopecia areata.

Pauci-follicular unit counts in alopecia biopsies can help to recognize and diagnose traction alopecia, according to a study.

The FDA has approved Litfulo, a once-daily oral treatment, for the treatment of severe alopecia in individuals aged 12 years and older, Pfizer announced in a press release.

The consumption of sugar-sweetened beverages and artificially sweetened drinks may be linked to male pattern hair loss, according to a study.

The European Medicines Agency has validated the marketing authorization application for coacillium for the treatment of moderate and severe alopecia areata in children and adolescents, Legacy Healthcare announced in a press release.

Revivv, a novel topical serum, led to meaningful improvements in hair growth with no adverse events in patients with androgenetic alopecia, according to a study.

Newborns of mothers with alopecia areata experienced a significantly greater risk for developing alopecia and accompanying comorbidities, according to a study.

Many people often consider alopecia — a disease characterized by chronic and sudden hair loss — to be exclusively a cosmetic disorder. Unlike many other chronic conditions, the disease itself does not increase mortality, and it is often not accompanied by physical pain.